The hOGG1 Ser326Cys polymorphism contributes to cancer susceptibility: Evidence from 83 case-control studies

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 329-336

  Wang, Wei ^a   Wang, Meilin ^b   Chen, Yuning ^c   Zhang, Zhizhong ^b   Wang, Shizhi ^b   Xu, Ming ^b   Wang, Baolin ^a   Zhao, Qinghong ^a   Zhang, Zhengdong ^b  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ZHEJIANG HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

8 OXOGUNAINE DNA GLYCOSYLASE PROTEIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; AUSTRALIA; BELGIUM; BLADDER CANCER; BREAST CANCER; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINA; COLORECTAL CANCER; DENMARK; ESOPHAGUS CANCER; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GERMANY; HEAD AND NECK CANCER; HUMAN; INDIA; ITALY; JAPAN; KOREA; LUNG CANCER; META ANALYSIS; NORWAY; POLAND; PRIORITY JOURNAL; PROSTATE CANCER; STOMACH CANCER; THAILAND; UNITED STATES;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; DNA GLYCOSYLASES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS;

EID: 84860201936     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger083     Document Type: Article

References (95)

1. Pharoah, P. D., Dunning, A. M., Ponder, B. A. and Easton, D. F. (2004) Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer, 4, 850-860.
2. Boiteux, S. and Radicella, J. P. (2000) The human OGG1 gene: structure, functions, and its implication in the process of carcinogenesis. Arch. Biochem. Biophys., 377, 1-8.
3. Kohno, T., Shinmura, K., Tosaka, M., Tani, M., Kim, S. R., Sugimura, H., Nohmi, T., Kasai, H. and Yokota, J. (1998) Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene, 16, 3219-3225.
4. Weiss, J. M., Goode, E. L., Ladiges, W. C. and Ulrich, C. M. (2005) Polymorphic variation in hOGG1 and risk of cancer: a review of the functional and epidemiologic literature. Mol. Carcinog., 42, 127-141.
5. Poplawski, T., Arabski, M., Kozirowska, D. et al. (2006) DNA damage and repair in gastric cancer-a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat. Res., 601, 83-91.
6. Capella, G., Pera, G., Sala, N. et al. (2008) DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int. J. Epidemiol., 37, 1316-1325.
7. Farinati, F., Cardin, R., Bortolami, M., Nitti, D., Basso, D., de Bernard, M., Cassaro, M., Sergio, A. and Rugge, M. (2008) Oxidative DNA damage in gastric cancer: CagA status and OGG1 gene polymorphism. Int. J. Cancer, 123, 51-55.
8. Shinmura, K., Kohno, T., Kasai, H., Koda, K., Sugimura, H. and Yokota, J. (1998) Infrequent mutations of the hOGG1 gene, that is involved in the excision of 8-hydroxyguanine in damaged DNA, in human gastric cancer. Jpn. J. Cancer Res., 89, 825-828.
9. Canbay, E., Agachan, B., Gulluoglu, M. et al. (2010) Possible associations of APE1 polymorphism with susceptibility and HOGG1 polymorphism with prognosis in gastric cancer. Anticancer Res., 30, 1359-1364.
10. Malik, M. A., Zargar, S. A. and Mittal, B. (2010) Lack of influence of DNA repair gene OGG1 codon 326 polymorphisms of gastric cancer risk in the Kashmir valley. Asian Pac. J. Cancer Prev., 11, 165-168.
11. Sun, L. M., Shang, Y., Zeng, Y. M., Deng, Y. Y. and Cheng, J. F. (2010) HOGG1 polymorphism in atrophic gastritis and gastric cancer after Helicobacter pylori eradication. World J. Gastroenterol., 16, 4476-4482.
12. Tsukino, H., Hanaoka, T., Otani, T. et al. (2004) hOGG1 Ser326Cys polymorphism, interaction with environmental exposures, and gastric cancer risk in Japanese populations. Cancer Sci., 95, 977-983.
13. Takezaki, T., Gao, C. M., Wu, J. Z. et al. (2002) hOGG1 Ser(326)Cys polymorphism and modification by environmental factors of stomach cancer risk in Chinese. Int. J. Cancer, 99, 624-627.
14. Hanaoka, T., Sugimura, H., Nagura, K. et al. (2001) hOGG1 exon7 polymorphism and gastric cancer in case-control studies of Japanese Brazilians and non-Japanese Brazilians. Cancer Lett., 170, 53-61.
15. Kim, J. I., Park, Y. J., Kim, K. H., Song, B. J., Lee, M. S., Kim, C. N. and Chang, S. H. (2003) hOGG1 Ser326Cys polymorphism modifies the significance of the environmental risk factor for colon cancer. World J. Gastroenterol., 9, 956-960.
16. Hansen, R., Saebo, M., Skjelbred, C. F. et al. (2005) GPX Pro198Leu and OGG1 Ser326Cys polymorphisms and risk of development of colorectal adenomas and colorectal cancer. Cancer Lett., 229, 85-91.
17. Curtin, K., Samowitz, W. S., Wolff, R. K., Ulrich, C. M., Caan, B. J., Potter, J. D. and Slattery, M. L. (2009) Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol. Biomarkers Prev., 18, 3384-3388.
18. Moreno, V., Gemignani, F., Landi, S. et al. (2006) Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res., 12, 2101-2108.
19. Stern, M. C., Conti, D. V., Siegmund, K. D., Corral, R., Yuan, J. M., Koh, W. P. and Yu, M. C. (2007) DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese Health Study. Cancer Epidemiol. Biomarkers Prev., 16, 2363-2372.
20. Park, H. W., Kim, I. J., Kang, H. C., Jang, S. G., Ahn, S. A., Lee, J. S., Shin, H. R. and Park, J. G. (2007) The hOGG1 Ser326Cys polymorphism is not associated with colorectal cancer risk. J. Epidemiol., 17, 156-160.
21. Pardini, B., Naccarati, A., Novotny, J. et al. (2008) DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res., 638, 146-153.
22. Hansen, R. D., Krath, B. N., Frederiksen, K. et al. (2009) GPX1 Pro(198)Leu polymorphism, erythrocyte GPX activity, interaction with alcohol consumption and smoking, and risk of colorectal cancer. Mutat. Res., 664, 13-19.
23. Sliwinski, T., Krupa, R., Wisniewska-Jarosinska, M., Pawlowska, E., Lech, J., Chojnacki, J. and Blasiak, J. (2009) Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population. Tohoku J. Exp. Med., 218, 185-191.
24. Engin, A. B., Karahalil, B., Engin, A. and Karakaya, A. E. (2010) Oxidative stress, Helicobacter pylori, and OGG1 Ser326Cys, XPC Lys939Gln, and XPD Lys751Gln polymorphisms in a Turkish population with colorectal carcinoma. Genet. Test. Mol. Biomarkers, 14, 559-564.
25. Obtulowicz, T., Swoboda, M., Speina, E. et al. (2010) Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients. Mutagenesis, 25, 463-471.
26. Xing, D. Y., Tan, W., Song, N. and Lin, D. X. (2001) Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int. J. Cancer, 95, 140-143.
27. Upadhyay, R., Malik, M. A., Zargar, S. A. and Mittal, B. OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of northern India. J. Gastrointest. Cancer, 41, 110-115.
28. Tse, D., Zhai, R., Zhou, W. et al. (2008) Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control, 19, 1077-1083.
29. Ferguson, H. R., Wild, C. P., Anderson, L. A. et al. (2008) No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship casecontrol study. Cancer Epidemiol. Biomarkers Prev., 17, 736-739.
30. Kim, E. J., Jeong, P., Quan, C. et al. (2005) Genotypes of TNF-alpha, VEGF, hOGG1, GSTM1, and GSTT1: useful determinants for clinical outcome of bladder cancer. Urology, 65, 70-75.
31. Karahalil, B., Kocabas, N. A. and Ozcelik, T. (2006) DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res., 26, 4955-4958.
32. Figueroa, J. D.,Malats,N.,Real, F. X. et al. (2007) Genetic variation in the base excision repair pathway and bladder cancer risk. Hum. Genet., 121, 233-242.
33. Arizono, K., Osada, Y. and Kuroda, Y. (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn. J. Clin. Oncol., 38, 186-191.
34. Narter, K. F., Ergen, A., Agachan, B., Gormus, U., Timirci, O. and Isbir, T. (2009) Bladder cancer and polymorphisms of DNA repair genes (XRCC1, XRCC3, XPD, XPG, APE1, hOGG1). Anticancer Res., 29, 1389-1393.
35. Chen, L., Elahi, A., Pow-Sang, J., Lazarus, P. and Park, J. (2003) Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J. Urol., 170, 2471-2474.
36. Nam, R. K., Zhang, W. W., Jewett, M. A. et al. (2005) The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin. Cancer Res., 11, 8391-8397.
37. Xu, J., Zheng, S. L., Turner, A. et al. (2002) Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res., 62, 2253-2257.
38. Nock, N. L., Cicek, M. S., Li, L., Liu, X., Rybicki, B. A., Moreira, A., Plummer, S. J., Casey, G. and Witte, J. S. (2006) Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk. Carcinogenesis, 27, 1842-1848.
39. Dhillon, V. S., Yeoh, E. and Fenech, M. (2009) DNA repair gene polymorphisms and prostate cancer risk in South Australia-results of a pilot study. Urol. Oncol., 29, 641-646.
40. Huang, W. Y., Gao, Y. T., Rashid, A. et al. (2008) Selected base excision repair gene polymorphisms and susceptibility to biliary tract cancer and biliary stones: a population-based case-control study in China. Carcinogenesis, 29, 100-105.
41. Srivastava, K., Srivastava, A. and Mittal, B. (2010) Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India. Cancer, 116, 3160-3169.
42. Jiao, X., Huang, J., Wu, S., Lv, M., Hu, Y., Jianfu, Su, X., Luo, C. and Ce, B. (2007) hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population. Int. J. Cancer, 121, 501-505.
43. Vogel, U., Nexo, B. A., Olsen, A., Thomsen, B., Jacobsen, N. R., Wallin, H., Overvad, K. and Tjonneland, A. (2003) No association between OGG1 Ser326Cys polymorphism and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 12, 170-171.
44. Choi, J. Y., Hamajima, N., Tajima, K. et al. (2003) hOGG1 Ser326Cys polymorphism and breast cancer risk among Asian women. Breast Cancer Res. Treat., 79, 59-62.
45. Rossner, P., Jr, Terry, M. B., Gammon, M. D. et al. (2006) OGG1 polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 811-815.
46. Cai, Q., Shu, X. O., Wen, W., Courtney, R., Dai, Q., Gao, Y. T. and Zheng, W. (2006) Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 15, 403-404.
47. Zhang, Y., Newcomb, P. A., Egan, K. M. et al. (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev., 15, 353-358.
48. Romanowicz-Makowska, H., Smolarz, B., Makowski, M., Polac, I. and Pertynski, T. (2008) Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women. Pol. J. Pathol., 59, 201-204.
49. Synowiec, E., Stefanska, J., Morawiec, Z., Blasiak, J. and Wozniak, K. (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat. Res., 648, 65-72.
50. Sangrajrang, S., Schmezer, P., Burkholder, I., Waas, P., Boffetta, P., Brennan, P., Bartsch, H., Wiangnon, S. and Popanda, O. (2008) Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res. Treat., 111, 279-288.
51. Loizidou, M. A., Michael, T., Neuhausen, S. L. et al. (2009) DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus. Breast Cancer Res. Treat., 115, 623-627.
52. Hsu, M. S., Yu, J. C., Wang, H. W., Chen, S. T., Hsiung, C. N., Ding, S. L., Wu, P. E., Shen, C. Y. and Cheng, C. W. (2009) Synergistic effects of polymorphisms in DNA repair genes and endogenous estrogen exposure on female breast cancer risk. Ann. Surg. Oncol., 17, 760-771.
53. Sterpone, S., Cornetta, T., Padua, L., Mastellone, V., Giammarino, D., Testa, A., Tirindelli, D., Cozzi, R. and Donato, V. DNA repair capacity and acute radiotherapy adverse effects in Italian breast cancer patients. Mutat. Res., 684, 43-48.
54. Yang, Y., Tian, H. and Zhang, Z. J. (2008) [Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 25, 211-213.
55. Elahi, A., Zheng, Z., Park, J., Eyring, K., McCaffrey, T. and Lazarus, P. (2002) The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis, 23, 1229-1234.
56. Cho, E. Y., Hildesheim, A., Chen, C. J. et al. (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol. Biomarkers Prev., 12, 1100-1104.
57. Pawlowska, E., Janik-Papis, K., Rydzanicz, M., Zuk, K., Kaczmarczyk, D., Olszewski, J., Szyfter, K., Blasiak, J. and Morawiec-Sztandera, A. (2009) The Cys326 allele of the 8-oxoguanine DNA N-glycosylase 1 gene as a risk factor in smoking- and drinking-associated larynx cancer. Tohoku J. Exp. Med., 219, 269-275.
58. Zhang, Z., Shi, Q., Wang, L. E., Sturgis, E. M., Spitz, M. R., El- Naggar, A. K., Hong, W. K. and Wei, Q. (2004) No Association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol. Biomarkers Prev., 13, 1081-1083.
59. Sliwinski, T., Przybylowska, K., Markiewicz, L. et al. (2010) MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study. Mol. Biol. Rep., 38, 1251-1261.
60. Wikman, H., Risch, A., Klimek, F. et al. (2000) hOGG1 polymorphism and loss of heterozygosity (LOH): significance for lung cancer susceptibility in a caucasian population. Int. J. Cancer, 88, 932-937.
61. Park, J., Chen, L., Tockman, M. S., Elahi, A. and Lazarus, P. (2004) The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics, 14, 103-109.
62. Zienolddiny, S., Campa, D., Lind, H., Ryberg, D., Skaug, V., Stangeland, L., Phillips, D. H., Canzian, F. and Haugen, A. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-567.
63. Loft, S., Svoboda, P., Kasai, H., Tjonneland, A., Vogel, U., Moller, P., Overvad, K. and Raaschou-Nielsen, O. (2006) Prospective study of 8-oxo- 7,8-dihydro-2'-deoxyguanosine excretion and the risk of lung cancer. Carcinogenesis, 27, 1245-1250.
64. Hatt, L., Loft, S., Risom, L., Moller, P., Sorensen, M., Raaschou-Nielsen, O., Overvad, K., Tjonneland, A. and Vogel, U. (2008) OGG1 expression and OGG1 Ser326Cys polymorphism and risk of lung cancer in a prospective study. Mutat. Res., 639, 45-54.
65. De Ruyck, K., Szaumkessel, M., De Rudder, I., Dehoorne, A., Vral, A., Claes, K., Velghe, A., Van Meerbeeck, J. and Thierens, H. (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat. Res., 631, 101-110.
66. Karahalil, B., Emerce, E., Kocer, B., Han, S., Alkis, N. and Karakaya, A. E. (2008) The association of OGG1 Ser326Cys polymorphism and urinary 8-OHdG levels with lung cancer susceptibility: a hospital-based case-control study in Turkey. Arh. Hig. Rada. Toksikol., 59, 241-250.
67. Miyaishi, A., Osawa, K., Osawa, Y. et al. (2009) MUTYH Gln324His gene polymorphism and genetic susceptibility for lung cancer in a Japanese population. J. Exp. Clin. Cancer Res., 28, 10.
68. Sugimura, H., Kohno, T., Wakai, K. et al. (1999) hOGG1 Ser326Cys polymorphism and lung cancer susceptibility. Cancer Epidemiol. Biomarkers Prev., 8, 669-674.
69. Sunaga, N., Kohno, T., Yanagitani, N. et al. (2002) Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol. Biomarkers Prev., 11, 730-738.
70. Le Marchand, L., Donlon, T., Lum-Jones, A., Seifried, A. andWilkens, L. R. (2002) Association of the hOGG1 Ser326Cys polymorphism with lung cancer risk. Cancer Epidemiol. Biomarkers Prev., 11, 409-412.
71. Lan, Q., Mumford, J. L., Shen, M. et al. (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis, 25, 2177-2181.
72. Vogel, U., Nexo, B. A., Wallin, H., Overvad, K., Tjonneland, A. and Raaschou-Nielsen, O. (2004) No association between base excision repair gene polymorphisms and risk of lung cancer. Biochem. Genet., 42, 453-460.
73. Liang, G., Pu, Y. and Yin, L. (2005) Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population. Cancer Lett., 223, 265-274.
74. Kohno, T., Kunitoh, H., Toyama, K. et al. (2006) Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk. Cancer Sci., 97, 724-728.
75. Chang, C. H., Hsiao, C. F., Chang, G. C. et al. (2009) Interactive effect of cigarette smoking with human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) polymorphisms on the risk of lung cancer: a case-control study in Taiwan. Am. J. Epidemiol., 170, 695-702.
76. Hung, R. J., Brennan, P., Canzian, F. et al. (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst., 97, 567-576.
77. Li, Z., Guan, W., Li, M. X., Zhong, Z. Y., Qian, C. Y., Yang, X. Q., Liao, L., Li, Z. P. and Wang, D. Genetic polymorphism of DNA baseexcision repair genes (APE1, OGG1 and XRCC1) and their correlation with risk of lung cancer in a Chinese population. Arch. Med. Res., 42, 226-234.
78. Sakamoto, T., Higaki, Y., Hara, M. et al. (2006) hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese. J. Epidemiol., 16, 233-239.
79. Dianzani, I., Gibello, L., Biava, A. et al. (2006) Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat. Res., 599, 124-134.
80. Vogel, U., Olsen, A., Wallin, H., Overvad, K., Tjonneland, A. and Nexo, B. A. (2004) No association between OGG1 Ser326Cys and risk of basal cell carcinoma. Cancer Epidemiol. Biomarkers Prev., 13, 1680-1681.
81. Habib, S. L., Danial, E., Nath, S., Schneider, J., Jenkinson, C. P., Duggirala, R., Abboud, H. E. and Thameem, F. (2008) Genetic polymorphisms in OGG1 and their association with angiomyolipoma, a benign kidney tumor in patients with tuberous sclerosis. Cancer Biol. Ther., 7, 23-27.
82. Zhao, H., Qin, C., Yan, F., Wu, B., Cao, Q., Wang, M., Zhang, Z. and Yin, C. hOGG1 Ser326Cys polymorphism and renal cell carcinoma risk in a Chinese population. DNA Cell Biol., 30, 317-321.
83. Stanczyk, M., Sliwinski, T., Cuchra, M., Zubowska, M., Bielecka- Kowalska, A., Kowalski, M., Szemraj, J., Mlynarski, W. and Majsterek, I. The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol. Biol. Rep., 38, 445-451.
84. Niwa, Y., Matsuo, K., Ito, H. et al. (2005) Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol. Oncol., 99, 43-49.
85. Krupa, R., Sobczuk, A., Poplawski, T., Wozniak, K. and Blasiak, J. DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism. Mol. Biol. Rep., 38, 1163-1170.
86. Li, H., Hao, X., Zhang, W., Wei, Q. and Chen, K. (2008) The hOGG1 Ser326Cys polymorphism and lung cancer risk: a meta-analysis. Cancer Epidemiol. Biomarkers Prev., 17, 1739-1745.
87. Gu, D., Wang, M., Zhang, Z. and Chen, J. Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case-control studies. Breast Cancer Res. Treat., 122, 527-531.
88. Yuan, W., Xu, L., Feng, Y., Yang, Y., Chen, W., Wang, J., Pang, D. and Li, D. (2010) The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis. Breast Cancer Res. Treat., 122, 835-842.
89. Handoll, H. H. (2006) Systematic reviews on rehabilitation interventions. Arch. Phys. Med. Rehabil., 87, 875.
90. DerSimonian, R. and Laird, N. (1986) Meta-analysis in clinical trials. Control Clin. Trials, 7, 177-188.
91. Mantel, N. and Haenszel, W. (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst., 22, 719-748.
92. Roy, D. and Liehr, J. G. (1999) Estrogen, DNA damage and mutations. Mutat. Res., 424, 107-115.
93. Yoshie, Y. and Ohshima, H. (1998) Synergistic induction of DNA strand breakage by catechol-estrogen and nitric oxide: implications for hormonal carcinogenesis. Free Radic. Biol. Med., 24, 341-348.
94. Schaid, D. J. and Jacobsen, S. J. (1999) Biased tests of association: comparisons of allele frequencies when departing from Hardy-Weinberg proportions. Am. J. Epidemiol., 149, 706-711.
95. Deng, H. W., Chen, W. M. and Recker, R. R. (2001) Population admixture: detection by Hardy-Weinberg test and its quantitative effects on linkagedisequilibrium methods for localizing genes underlying complex traits. Genetics, 157, 885-897.